Johnson & Johnson (NYSE:JNJ) announced today that it entered into a definitive agreement to acquire Atraverse Medical.

Johnson & Johnson (NYSE:JNJ) is one of the best low volatility stocks to invest in right now. On April 24, Johnson & Johnson ...

Data reinforce safety, reduced RF delivery, and consistent performance across workflows; company to showcase system at HRS 2026, Booth 2410 SAN DIEGO, April 22, 2026 /PRNewswire/ -- Atraverse Medical, ...

Johnson & Johnson (NYSE:JNJ) said on Friday it has agreed to acquire Atraverse Medical, Inc., a privately held medical device ...

New York, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Market Study on Transseptal Access Systems: Increasing Need for Efficient Atrial Fibrillation ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Among patients who underwent transcatheter valve-in-valve repair of a failed surgical mitral ...

The system offers zero-exchange delivery with a unique atraumatic design to reduce steps and eliminate rewiring during access ...

Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.

Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its ...

Atraverse Medical, a pioneer in next-generation left-heart access technology, today announced accelerating market uptake for ...